Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (37)
  • Open Access

    COMMUNICATION

    Gastrointestinal resection is associated with urolithiasis severity among inflammatory bowel disease patients

    Vinay Durbhakula1,*, Ziv Savin1, Einat Savin-Shalom2, Stephanie L. Gold2, Kavita Gupta1, Eve Frangopoulos1, Blair Gallante1, William M. Atallah1, Mantu Gupta1

    Canadian Journal of Urology, Vol.32, No.6, pp. 659-668, 2025, DOI:10.32604/cju.2025.067614 - 30 December 2025

    Abstract Background: A well-established correlation exists between Inflammatory Bowel Disease (IBD) and urolithiasis. However, the influence of surgical history on the severity of urolithiasis in IBD patients remains underexplored. This study aims to investigate the association between gastrointestinal (GI) bowel resection and urolithiasis severity in patients with IBD. Methods: This retrospective cohort study analyzed 42 patients diagnosed with both IBD and urolithiasis between 2016 and 2024. Patients were categorized based on their history of bowel resection. Primary outcomes included maximal stone burden, need for urolithiasis surgery, and stone recurrence. Secondary outcomes were stone-related clinical events, multiple… More >

  • Open Access

    REVIEW

    Biomarkers and Underlying Pathways for Prediction of Response to Vedolizumab Therapy in Inflammatory Bowel Disease

    Gloria Krajnc1, Lara Metlika2, Uroš Potočnik1,2,3, Boris Gole2,*

    BIOCELL, Vol.49, No.6, pp. 991-1017, 2025, DOI:10.32604/biocell.2025.063486 - 24 June 2025

    Abstract Vedolizumab is a humanized monoclonal antibody and one of the safest biologics for the treatment of both forms of inflammatory bowel disease (IBD)-Crohn’s disease and ulcerative colitis. It targets the α4β7 integrin and blocks leukocyte trafficking to the gut. Regardless of its efficacy in many patients, non-response to vedolizumab treatment poses a significant clinical challenge. In this review, we synthesize recent findings on genomic, transcriptomic, proteomic, and cellular biomarkers of vedolizumab response, emphasizing their roles in predicting therapeutic outcomes and understanding non-responsiveness. Key insights include the identification of epigenetic and transcriptomic signatures, the involvement of More >

  • Open Access

    ARTICLE

    Transperineal prostate biopsy without routine antibiotics demonstrates decreased infection risk

    Benjamin J. Lichtbroun1,2,*, Mann Patel2, Alexis Consalvo2, Labeeqa Khizir2, Munisa Said2, Austin Chien2, Kevin Chua1,2, John Pfail1,2, Rachel Passarelli1,2, Vignesh T. Packiam1, David Golombos1, Sammy Elsamra2, Thomas L. Jang1, Arnav Srivastava1,3, Saum Ghodoussipour1

    Canadian Journal of Urology, Vol.32, No.1, pp. 55-62, 2025, DOI:10.32604/cju.2025.064701 - 20 March 2025

    Abstract Introduction: Infections are the most feared complication of transrectal prostate biopsies, along with growing concerns of antibiotic resistance. Our institution transitioned to a transperineal approach without use of perioperative antibiotics or bowel preparations. We aimed to compare the safety outcomes associated with transperineal and transrectal prostate biopsy techniques. Materials and Methods: A retrospective analysis of patients who underwent transrectal and transperineal prostate biopsies at our institution from 2019–2022 was performed. Results: We identified 319 patients—174 transrectal and 145 transperineal. 8 patients who had transperineal biopsy (5.5%) received peri-operative antibiotics, compared to 100% with transrectal biopsy. 35.86%… More >

  • Open Access

    REVIEW

    The genetics of pediatric inflammatory bowel disease: Towards precision medicine

    AHMAD SHAHIR MOHAMAD NAZRI, NAZIHAH MOHD YUNUS, MARAHAINI MUSA*

    BIOCELL, Vol.49, No.1, pp. 149-160, 2025, DOI:10.32604/biocell.2024.057352 - 24 January 2025

    Abstract Pediatric inflammatory bowel disease (IBD) is a chronic and heterogeneous disease. IBD is commonly classified into Crohn’s disease and ulcerative colitis. It is linked to serious symptoms and complications. The onset of IBD commonly occurs during adolescence. Despite the significant number of cases globally (~5 million), the causes of pediatric IBD, which constitutes 25% of IBD patients, are not yet fully understood. Apart from environmental factors, genetic factors contribute to a higher risk of developing IBD. The predisposition risk of IBD can be investigated using genetic testing. Genetic mechanisms of pediatric IBD are highly complex More >

  • Open Access

    ARTICLE

    Numerical Simulation of Gas-LiquId Flow in a Horizontal Elbow

    Lihui Ma1, Wei Li1, Yuanyuan Wang1, Pan Zhang1, Lina Wang1, Xinying Liu1, Meiqin Dong2, Xuewen Cao2, Jiang Bian3,*

    FDMP-Fluid Dynamics & Materials Processing, Vol.21, No.1, pp. 107-119, 2025, DOI:10.32604/fdmp.2024.058295 - 24 January 2025

    Abstract Gas-liquid flow (GLF), especially slug and annular flows in oil and gas gathering and transportation pipelines, become particularly complex inside elbows and can easily exacerbate pipeline corrosion and damage. In this study, FLUENT was used to conduct 3D simulations of slug and annular flow in elbows for different velocities to assess the ensuing changes in terms of pressure. In particular, the multifluid VOF (Volume of Fraction) model was chosen. The results indicate that under both slug and annular flow conditions, the pressure inside the elbow is lower than the outside. As the superficial velocity More >

  • Open Access

    ARTICLE

    Antibody targeting TSLP suppresses DSS-induced colitis and activation of the JAK2/STAT5 pathway in mice

    Wei Zhuang, Zhen Li

    European Cytokine Network, Vol.34, No.4, pp. 46-53, 2023, DOI:10.1684/ecn.2023.0489

    Abstract Background: There is currently no safe or effective treatment for inflammatory bowel disease (IBD), which is defined as recurrent and persistent intestinal inflammation. Thymic stromal lymphopoietin (TSLP) has been shown to be associated with the pathogenesis of IBD, and the JAK2/STAT5 signalling pathway has demonstrated much promise as a novel therapeutic target for IBD. Materials and Methods: In this study, we first evaluated levels of TSLP in dextran sodium sulphate (DSS)-induced IBD mice. Second, we applied tezepelumab, an anti-TSLP monoclonal antibody (20 µg per mouse, intraperitoneally), to DSS-induced IBD mice and quantified the signs of histopathological change,… More >

  • Open Access

    EDITORIAL

    The Bladder and the Bowel: More Than Just Neighbors

    Leonard G. Gomella

    Canadian Journal of Urology, Vol.30, No.4, pp. 11583-11583, 2023

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    Deep Learning-Based Digital Image Forgery Detection Using Transfer Learning

    Emad Ul Haq Qazi1,*, Tanveer Zia1, Muhammad Imran2, Muhammad Hamza Faheem1

    Intelligent Automation & Soft Computing, Vol.38, No.3, pp. 225-240, 2023, DOI:10.32604/iasc.2023.041181 - 27 February 2024

    Abstract Deep learning is considered one of the most efficient and reliable methods through which the legitimacy of a digital image can be verified. In the current cyber world where deepfakes have shaken the global community, confirming the legitimacy of a digital image is of great importance. With the advancements made in deep learning techniques, now we can efficiently train and develop state-of-the-art digital image forensic models. The most traditional and widely used method by researchers is convolution neural networks (CNN) for verification of image authenticity but it consumes a considerable number of resources and requires… More >

  • Open Access

    ARTICLE

    Bioinformatic analysis and in vivo validation of angiogenesis related genes in inflammatory bowel disease

    ZEPENG DONG, CHENYE ZHAO, SHIBO HU, KUI YANG, JUNHUI YU*, XUEJUN SUN, JIANBAO ZHENG*

    BIOCELL, Vol.47, No.12, pp. 2735-2745, 2023, DOI:10.32604/biocell.2023.043422 - 27 December 2023

    Abstract Objectives: Angiogenesis plays a significant role in the occurrence and development of inflammatory bowel disease (IBD). The aim of this study is to explore potential angiogenesis related genes (ARGs) in IBD through bioinformatics analysis and in vivo experiments. Methods: GSE57945, GSE87466, and GSE36807 were obtained from the Gene Expression Omnibus database. GSE57945 was used as the training set, while GSE87466 and GSE36807 were used as the validation set. The key ARGs associated with IBD were identified using the least absolute shrinkage and selection operator (LASSO) and random forest methods. These identified ARGs were then utilized to construct… More >

  • Open Access

    REVIEW

    Curcumin in inflammatory bowel diseases: Cellular targets and molecular mechanisms

    AMYLLY SANUELLY DA PAZ MARTINS1,#, MARLA DE CERQUEIRA ALVES2,#, ORLANDO ROBERTO PIMENTEL DE ARAÚJO3, FABIANA OLIVEIRA DOS SANTOS CAMATARI4, MARÍLIA OLIVEIRA FONSECA GOULART1,3,5, FABIANA ANDRÉA MOURA2,6,*

    BIOCELL, Vol.47, No.11, pp. 2547-2566, 2023, DOI:10.32604/biocell.2023.043253 - 27 November 2023

    Abstract

    Curcumin, a natural product, has exhibited promising effects in both animal models and clinical trials, interacting with a multitude of factors linked to Inflammatory Bowel Disease (IBD). These factors encompass cytokines, oxidative stress-associated enzymes, and modulation of the intestinal microbiota. Notably, curcumin has demonstrated therapeutic potential in animal models of colitis, wherein it exerts a negative regulatory influence on pivotal signaling pathways such as PI3/Akt, JAK/STAT, and β-catenin. Moreover, it inhibits the expression of pro-inflammatory enzymes and co-stimulatory molecules (including RANKL, ICAM-1, CD205, CD256, TLR4, among others), while curbing immune cell chemotaxis, thereby attenuating the characteristic

    More > Graphic Abstract

    Curcumin in inflammatory bowel diseases: Cellular targets and molecular mechanisms

Displaying 1-10 on page 1 of 37. Per Page